1K74 image
Deposition Date 2001-10-18
Release Date 2001-12-05
Last Version Date 2024-02-07
Entry Detail
PDB ID:
1K74
Keywords:
Title:
The 2.3 Angstrom resolution crystal structure of the heterodimer of the human PPARgamma and RXRalpha ligand binding domains respectively bound with GW409544 and 9-cis retinoic acid and co-activator peptides.
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.30 Å
R-Value Free:
0.27
R-Value Work:
0.23
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Retinoic acid receptor RXR-alpha
Gene (Uniprot):RXRA
Chain IDs:A
Chain Length:238
Number of Molecules:1
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:steroid receptor coactivator
Chain IDs:C (auth: B), D (auth: E)
Chain Length:25
Number of Molecules:2
Biological Source:
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Peroxisome proliferator activated receptor gamma
Gene (Uniprot):PPARG
Chain IDs:B (auth: D)
Chain Length:283
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.
Proc.Natl.Acad.Sci.USA 98 13919 13924 (2001)
PMID: 11698662 DOI: 10.1073/pnas.241410198

Abstact

The peroxisome proliferator-activated receptors (PPARs) are transcriptional regulators of glucose, lipid, and cholesterol metabolism. We report the x-ray crystal structure of the ligand binding domain of PPAR alpha (NR1C1) as a complex with the agonist ligand GW409544 and a coactivator motif from the steroid receptor coactivator 1. Through comparison of the crystal structures of the ligand binding domains of the three human PPARs, we have identified molecular determinants of subtype selectivity. A single amino acid, which is tyrosine in PPAR alpha and histidine in PPAR gamma, imparts subtype selectivity for both thiazolidinedione and nonthiazolidinedione ligands. The availability of high-resolution cocrystal structures of the three PPAR subtypes will aid the design of drugs for the treatments of metabolic and cardiovascular diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback